TerrAscend (TSNDF) Depreciation & Amortization - Total (2021 - 2026)

TerrAscend (TSNDF) reported Depreciation & Amortization - Total of $2.4 million for Q1 2026, down 1.75% year-over-year from $2.4 million in Q1 2025, and up 2.74% quarter-over-quarter from $2.3 million in Q4 2025.

TerrAscend (TSNDF) Depreciation & Amortization - Total (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Depreciation & Amortization - Total data on file, last reported at $2.4 million in Q1 2026.

  • Depreciation & Amortization - Total for Q1 2026 came in at $2.4 million, down 1.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.1 million (changed 0.46% YoY), and the FY2025 annual result was $9.1 million, up 2.09% from the prior year.
  • Depreciation & Amortization - Total advanced to $2.4 million in Q1 2026 per TSNDF's latest filing, from $2.3 million in the prior quarter.
  • Over five years, Depreciation & Amortization - Total peaked at $3.4 million in Q2 2023 and troughed at -$1.0 million in Q4 2023.
  • A 5-year average of $2.3 million and a median of $2.4 million in 2026 frame the typical range for Depreciation & Amortization - Total.
  • The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization - Total surged 986.94% in 2022, then slumped 142.93% in 2023.
  • A 5-year view of Depreciation & Amortization - Total shows it stood at $2.4 million in 2022, then plunged by 142.93% to -$1.0 million in 2023, then surged by 322.3% to $2.3 million in 2024, then dropped by 0.09% to $2.3 million in 2025, then increased by 2.74% to $2.4 million in 2026.
  • Business Quant data shows TSNDF's Depreciation & Amortization - Total at $2.4 million in Q1 2026, $2.3 million in Q4 2025, and $2.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 TerrAscend - - 34.60 Mn 2.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.36 Mn
Dec 31, 2025 2.30 Mn
Sep 30, 2025 2.20 Mn
Jun 30, 2025 2.24 Mn
Mar 31, 2025 2.41 Mn
Dec 31, 2024 2.30 Mn
Sep 30, 2024 2.23 Mn
Jun 30, 2024 2.21 Mn
Mar 31, 2024 3.04 Mn
Dec 31, 2023 -1.04 Mn
Sep 30, 2023 2.48 Mn
Jun 30, 2023 3.40 Mn
Mar 31, 2023 3.26 Mn
Dec 31, 2022 2.41 Mn
Sep 30, 2022 2.71 Mn
Jun 30, 2022 3.03 Mn
Mar 31, 2022 2.19 Mn
Dec 31, 2021 222,000.00
Sep 30, 2021 2.14 Mn
Jun 30, 2021 1.81 Mn